Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: A report from the African American Study of Kidney Disease (AASK) Trial

1985 National Health Survey, 1966 Lopes, 1993, The excess risk of treated end-stage renal disease in blacks in the United States, J Am Soc Nephrol, 3, 1961, 10.1681/ASN.V3121961 Feldman, 1992, End-stage renal disease in US minority groups, Am J Kidney Dis, 19, 397, 10.1016/S0272-6386(12)80945-0 Blythe, 1991, Hypertension as a causative diagnosis of patients entering end-stage renal disease programs in the United States from 1980 to 1986, Am J Kidney Dis, 18, 33, 10.1016/S0272-6386(12)80287-3 U.S. Renal Data System, 1995 Dustan, 1987, Systemic hypertension and the kidney in black patients, Am J Cardiol, 60, 731, 10.1016/0002-9149(87)90464-4 Messerli, 1987, Disparate cardiovascular findings in men and women with essential hypertension, Annals Int Med, 107, 158, 10.7326/0003-4819-107-2-158 Hall, 1984, Role of renal hemodynamics and arterial pressure in aldosterone “escape”, Hypertension, 6, I183, 10.1161/01.HYP.6.2_Pt_2.I183 Dustan, 1986, Excessive sodium retention as a characteristic of salt-sensitive hypertension, Am J Med Sci, 292, 67, 10.1097/00000441-198608000-00001 Messerli, 1979, Essential hypertension in black and white subjects—Hemodynamic findings and fluid volume state, Am J Med, 67, 27, 10.1016/0002-9343(79)90065-2 Frohlich, 1984, Greater renal vascular involvement in the black patient with essential hypertension. A comparison of systemic and renal hemodynamics in black and white patients, Miner Electrol Metab, 10, 173 Entwisle, 1977, Target organ damage in black hypertensives, Circulation, 55, 792, 10.1161/01.CIR.55.5.792 Kaplan, 1986, Hypertension in the population at large, 1 McClellan, 1988, Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension, Am J Kidney Dis, 12, 285, 10.1016/S0272-6386(88)80221-X Whittle, 1991, Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease, Arch Intern Med, 151, 1359, 10.1001/archinte.1991.00400070121015 Shulman, 1989, Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group, Hypertension, 13, I80 Harvey, 1992, Renal biopsy findings in hypertensive patients with proteinuria, Lancet, 340, 1435, 10.1016/0140-6736(92)92624-O Perneger, 1995, Diagnosis of hypertensive end-stage renal disease: Effect of patient's race, Am J Epidemiol, 141, 10, 10.1093/oxfordjournals.aje.a117338 Wright, 1994, The design of the African-American Study of Kidney Disease and Hypertension (AASK), J Am Soc Nephrol, 5, 570 Whelton, 1994, Recruitment in the African-American Study of Kidney Disease and Hypertension (AASK) pilot study, J Am Soc Nephrol, 5, 470 Israelit, 1973, Measurement of glomerular filtration rate utilizing a single subcutaneous injection of 125I-iothalamate, Kidney Int, 4, 346, 10.1038/ki.1973.127 Kaplan, 1975, Age-related incidence of sclerotic glomeruli in human kidneys, Am J Pathol, 80, 227 Kappel, 1980, Cortical interstitial tissue and sclerosed glomeruli in the normal human kidney, related to age and sex. A quantitative study, Virchows Arch (Pathol Anat), 387, 271, 10.1007/BF00454830 Smith, 1989, Low incidence of glomerulosclerosis in normal kidneys, Arch Pathol Lab Med, 113, 1253 Nash, 1976, The significance of focal sclerotic lesions of glomeruli in children, J Pediatr, 88, 806, 10.1016/S0022-3476(76)81119-5 Heptinstall, 1992, Hypertension I: Essential hypertension, 962 Striker, 1990, Renal lesions in hypertension, 8, 241 Katz, 1979, Glomerular lesions in benign essential hypertension, Arch Pathol Lab Med, 103, 199 Narvarte, 1987, Proteinuria in hypertension, Am J Kidney Dis, 10, 408, 10.1016/S0272-6386(87)80186-5 Morduchowicz, 1986, Proteinuria in benign nephrosclerosis, Arch Intern Med, 146, 1513, 10.1001/archinte.1986.00360200063011 Morduchowicz, 1986, Proteinuria in benign nephrosclerosis, Arch Intern Med, 146, 1513, 10.1001/archinte.1986.00360200063011 Innes, 1993, Clinical features of benign hypertensive nephrosclerosis at time of renal biopsy, Quart J Med, 86, 271 Tracy, 1993, Nephrosclerosis in three cohorts of black and white men born 1925 to 1944, 1934 to 1953, and 1943 to 1962, Am J Hypertens, 6, 185, 10.1016/j.jash.2012.02.001 U.S. Vital Health Statistics, 1986, Blood pressure levels in persons 18–74 years of age in 1976–80, and trends in blood pressure from 1960 to 1980 in the United States, National Health Survey Series, 11, 48 Summers, 1958, Histologic studies of kidney biopsy specimens from patients with hypertension, Am J Pathol, 34, 685 Zollinger, 1978, Renal changes caused by vascular disease, 514 Kincaid-Smith, 1987, Hypertension and the Kidney, 131 Rostand, 1989, Renal insufficiency in treated essential hypertension, N Engl J Med, 320, 684, 10.1056/NEJM198903163201102 Walker, 1992, Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects, JAMA, 268, 3085, 10.1001/jama.1992.03490210067037 Freedman, 1995, The link between hypertension and nephrosclerosis, Am J Kidney Dis, 25, 207, 10.1016/0272-6386(95)90001-2 Freedman, 1994, Renal biopsy findings in presumed hypertensive nephrosclerosis, Am J Nephrol, 14, 90, 10.1159/000168695 Tamura, 1966, Histologic features of renal biopsies from patients with essential hypertension and from the aged, Jpn Circ J, 30, 829, 10.1253/jcj.30.829 Katafuchi, 1987, Morphometrical and functional correlations in benign nephrosclerosis, Clin Nephrol, 28, 238 Harvey, 1992, Renal biopsy findings in hypertensive patients with proteinuria, Lancet, 340, 1435, 10.1016/0140-6736(92)92624-O Freedman, 1993, The familial risk of end-stage renal disease in African Americans, Am J Kidney Dis, 21, 387, 10.1016/S0272-6386(12)80266-6 Ferguson, 1988, A familial risk of chronic renal failure among blacks on dialysis, J Clin Epidemiol, 41, 1189, 10.1016/0895-4356(88)90023-6 Teio, 1995, Angiotensin converting enzyme genotypes and disease, Brit Med J, 311, 76 Bloem, 1995, The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children, J Clin Invest, 95, 948, 10.1172/JCI117803 Rutledge, 1995, Polymorphism of the angiotensin I converting enzyme gene in essential hypertensive patients, Biochem Mol Biol Int, 35, 661 Duru, 1994, Frequency of a deletion polymorphism in the gene for angiotensin converting enzyme is increased in African-Americans with hypertension, Am J Hypertens, 7, 759, 10.1093/ajh/7.8.759 Hunley, 1996, Angiotensin converting enzyme gene polymorphism: Potential silencer motif and impact on progression in IgA nephropathy, Kidney Int, 49, 571, 10.1038/ki.1996.81 Yoshida, 1995, Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy, J Clin Invest, 96, 2162, 10.1172/JCI118270 Jacobsen, 1995, The insertion/deletion (I/O) polymorphism in the angiotensin-I-converting enzyme (ACE) gene predicts the progression of diabetic nephropathy during ACE inhibition (ACEI) in insulin dependent diabetic (IDDM) patients, J Am Soc Nephrol, 6, 450 Rigat, 1990, An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels, J Clin Invest, 86, 1343, 10.1172/JCI114844 Ueda, 1995, Enhanced pressor response to angiotensin I in normotensive men with the deletion geneotype (DD) for angiotensin-converting enzyme, Hypertension, 25, 1266, 10.1161/01.HYP.25.6.1266 Pesce, 1994, Glomerular size and the incidence of renal disease in African Americans and Caucasians, J Nephrol, 7, 355 Brenner, 1994, Congenital oligonephropathy and the etiology of adult hypertension and progressive renal injury, Am J Kidney Dis, 23, 171, 10.1016/S0272-6386(12)80967-X Hack, 1995, Preterm delivery and low birth weight—A dire legacy, N Engl J Med, 333, 1772, 10.1056/NEJM199512283332611 Fogo, 1990, Importance of angiogenic action of angiotensin II in the glomerular growth of maturing kidneys, Kidney Int, 38, 1068, 10.1038/ki.1990.314 Tanaka, 1994, Angiotensin converting enzyme inhibitor modulates glomerular function and structure by distinct mechanisms, Kidney Int, 45, 537, 10.1038/ki.1994.69 Anderson, 1994, Glomerular adaptations with normal aging and with long-term converting enzyme inhibition in rats, Am J Physiol, 267, F35 Heudes, 1994, Effect of chronic Ang I-converting enzyme inhibition on aging processes: I. Kidney structure and function, Am J Physiol, 266, R1038 Michel, 1994, Effect of chronic Ang I-converting enzyme inhibition on aging processes: II. Large arteries, Am J Physiol, 267, R124